Franklin Stuart Friedman

Insider Reports History

Location
Waltham, MA
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Franklin Stuart Friedman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Deciphera Pharmaceuticals, Inc. Director Common Stock 0 $0 $15.62 11 Jun 2024 Direct
Deciphera Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 $0 $10.58 11 Jun 2024 Direct

Insider Reports Filed by Franklin Stuart Friedman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NA Deciphera Pharmaceuticals, Inc. 11 Jun 2024 6 $0 4 Director 11 Jun 2024, 20:49
DCPH Deciphera Pharmaceuticals, Inc. 16 Jan 2024 1 $50,003 4 Director 18 Jan 2024, 16:15
DCPH Deciphera Pharmaceuticals, Inc. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:05
DCPH Deciphera Pharmaceuticals, Inc. 08 Jun 2023 1 $138,828 4 Director 12 Jun 2023, 16:05
DCPH Deciphera Pharmaceuticals, Inc. 17 Jan 2023 1 $50,000 4 Director 19 Jan 2023, 15:06
DCPH Deciphera Pharmaceuticals, Inc. 23 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:05
DCPH Deciphera Pharmaceuticals, Inc. 18 Jan 2022 1 $49,955 4 Director 20 Jan 2022, 16:00
DCPH Deciphera Pharmaceuticals, Inc. 23 Jun 2021 1 $0 4 Director 25 Jun 2021, 16:00